Trends & Forecasts

An early wave of investor enthusiasm followed by an economic crisis has landed our field in a sea of trouble – so how can we swim to shore?

Snapshots, sketches, and secrets of Lithuania’s burgeoning life sciences scene.

In the face of war and the economic fallout of COVID-19, Europe is weathering an energy price storm. What does this mean for medicine makers?

What can cell and gene do to avoid a seemingly inevitable rush on supporting products and services?

Everything you ever wanted to know (but were too afraid to ask) about in vivo and ex vivo lentiviral vector therapies

More than a few pearls of wisdom were dropped at this key gathering in London, and we were there to catch them.

From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect

The importance of collaborative efforts in generating new vaccines to protect a vulnerable world

In the face of economic uncertainty in a post-pandemic world, how will the cell and gene field respond?

A year of turmoil, and a year of change – just how healthy are pharma and the life sciences?